Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001369568

SEC filings (opens in a new tab)

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of CPRX: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	186	4	190	+8
Shares	70.7M	572.8K	75.5M	+5.36M (+7.6%)
Value	$585.5M	$4.75M	$531.7M	−$49.0M (−8.4%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CPRX in Q2 2022
Institution	Shares	Value	% of portfolio
Advisors Asset Management, Inc.	248,522	$1.74M	0.03%
HRT Financial LP	188,119	$1.32M	0.01%
Martingale Asset Management L P	101,702	$714.0K	0.01%
Capital Fund Management S.A.	60,826	$426.4K	0.01%
New York Life Investment Management LLC	56,253	$394.0K	0.00%
Yorktown Management & Research Co Inc	50,000	$351.0K	0.45%
Vestcor Inc	35,027	$246.0K	0.01%
Miller Howard Investments Inc	31,485	$221.0K	0.01%
Jupiter Asset Management Ltd	30,687	$215.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	27,602	$193.0K	0.00%
Algert Global LLC	26,090	$183.0K	0.01%
Raymond James & Associates	22,324	$156.0K	0.00%
Eqis Capital Management, Inc.	18,901	$132.5K	0.01%
Y-Intercept (Hong Kong) Ltd	18,563	$130.0K	0.02%
Ingalls & Snyder LLC	15,000	$105.0K	0.01%
MML Investors Services, LLC	11,621	$81.0K	0.00%
Quantamental Technologies LLC	10,296	$72.0K	0.03%
Aquatic Capital Management LLC	7,800	$55.0K	0.02%
Leonteq Securities AG	4,000	$28.0K	0.00%
Nisa Investment Advisors, LLC	2,320	$16.0K	0.00%
Ensign Peak Advisors, Inc	1,420	$10.0K	0.00%
Urban Wealth Management, LLC	1,253	$9.00K	0.03%
Bangor Savings Bank	100	$1.00K	0.00%
Signaturefd, LLC	34	$0	0.00%
Ronald Blue Trust, Inc.	35	$0	0.00%

Sold out (17)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CPRX in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Natixis	225,377	$1.87M
APG Asset Management N.V.	146,700	$1.09M
AdvisorShares Investments LLC	36,100	$299.0K
Lanham O'Dell & Company, Inc.	26,500	$220.0K
Occudo Quantitative Strategies LP	26,060	$216.0K
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	24,534	$203.0K
Connor, Clark & Lunn Investment Management Ltd.	24,431	$203.0K
Graham Capital Management, L.P.	24,356	$201.0K
Schonfeld Strategic Advisors LLC	23,288	$193.0K
Cornerstone Investment Partners, LLC	22,925	$190.0K
GWM Advisors LLC	19,189	$159.0K
Mirabella Financial Services LLP	15,597	$129.0K
USA Financial Portformulas Corp	12,870	$107.0K
Nkcfo LLC	12,000	$99.0K
Blueshift Asset Management, LLC	10,941	$91.0K
Group One Trading, L.P.	9,242	$77.0K
Quantbot Technologies LP	7,500	$62.0K

Not filed for Q2 2022 yet (4)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CPRX in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	341,584	$2.83M
Virginia Retirement Systems Et Al	168,700	$1.40M
IndexIQ Advisors LLC	50,802	$421.0K
Amalgamated Financial Corp.	11,690	$97.0K